Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mydecine Innovations Group Inc
C.MYCO
Alternate Symbol(s):
MYCOF
Healthcare
Advertising Agencies
Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired...
regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MYCO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 15, 2022 9:47pm
New Press Release - Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2022
DENVER, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financial results for the six months ended...
read article.
(6)
•••
Bigboypants
X
View Profile
View Bullboard History
Post by
Bigboypants
on Aug 15, 2022 1:56pm
Possible delisting.
https://www.stockwatch.com/News/Item/Z-C!MYCO-3291845/C/MYCO
(6)
•••
Bigboypants
X
View Profile
View Bullboard History
Post by
Bigboypants
on Aug 15, 2022 1:55pm
Suspended !
Looks like they are haulted regarding review by the NEO exchange.
(288)
•••
tired8
X
View Profile
View Bullboard History
Comment by
tired8
on Aug 15, 2022 10:22am
RE:Mydecine halted at the open
Chapter 11 ?
(0)
•••
Bell4545
X
View Profile
View Bullboard History
Post by
Bell4545
on Aug 15, 2022 10:04am
Mydecine halted at the open
Mydecine halted at the open 2022-08-15 07:08 ET - Halt Trading Mydecine Innovations Group Inc. has been halted effective at the open on Aug. 15, 2022. Anyone heard
...more
(3213)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Aug 10, 2022 5:23pm
Microdose Announces The 2nd Annual Microdose Awards
Miami, Florida--(Newsfile Corp. - August 9, 2022) - Microdose Psychedelic Insights, the leading guide to the business of psychedelics, is excited to announce the lineup of categories for the 2nd
...more
(3)
•••
zubry
X
View Profile
View Bullboard History
Post by
zubry
on Jul 19, 2022 11:56am
Fak JB
Keep applying for patents dipshite. Maybe you get one approve b4 the lock your doors
(2)
•••
Blackpenny
X
View Profile
View Bullboard History
Post by
Blackpenny
on Jun 27, 2022 10:10am
ask @ $38.76
Dreaming.....................
(503)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Jun 17, 2022 5:20pm
Cleared by FDA for psilocybin-based smoking cessation trial
https://themarketherald.ca/mydecine-neomyco-cleared-by-fda-for-psilocybin-based-smoking-cessation-trial-2022-06-17/
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 17, 2022 7:00am
New Press Release - U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation
DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology aiming to transform the treatment of mental health and addiction disorders, today announced that the U.S. Food and Drug Administration (FDA) has...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 09, 2022 7:00am
New Press Release - Mydecine Provides Company Update; Welcomes New Board Member
DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today provided an update on clinical trial and drug...
read article.
(1)
•••
bud13
X
View Profile
View Bullboard History
Post by
bud13
on Jun 01, 2022 4:15pm
Wow
what can anyone say on this! Can it get any worse? What happened? Or did they apparently have nothing to market
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 27, 2022 9:23am
New Press Release - Mydecine Announces Closing of Overnight Marketed Public Offering of Units
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/DENVER, May 27, 2022 /CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is pleased to announce that it has closed its previously announced best efforts overnight...
read article.
(5)
•••
virgintrader99
X
View Profile
View Bullboard History
Comment by
virgintrader99
on May 20, 2022 12:21am
RE:RE:Warrants Offering
Scam should be arrested them
(3)
•••
zubry
X
View Profile
View Bullboard History
Comment by
zubry
on May 19, 2022 2:21pm
RE:Warrants Offering
Either corrupt or inept management. Can't be both. I'm looking at you JB
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?